# HERCULES (NCT04224740)

> Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer

No report yet. It can be ordered.

- Indication: first-line advanced penile cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04224740
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Latin American Cooperative Oncology Group
- Conditions: Penile Carcinoma
- Interventions: Pembrolizumab; Standard of care therapy
- Enrollment: 37
- Primary outcome: Overall response rate (ORR)

## Indexed commentary on HERCULES so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 7
- Podcasts: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=hercules-nct04224740

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04224740", "email": "<work email>"}; the inbox owner confirms by the emailed link.